Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...

DexCom DXCM received a warning letter ... Abbott's FreeStyle Libre continuous glucose monitoring system (CGM) has seen significant growth, with sales surpassing $1.8 billion in the fourth quarter ...

The new device would give Dexcom a CGM that can be worn for as long as competitor Abbott’s Freestyle Libre 3 Plus sensor. COO Jake Leach said in a February earnings call that the company hopes to ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Dexcom advanced the launch of Stelo, its over-the-counter product for non-insulin type 2 diabetes, pre-diabetes, and ...

A supply-chain snag due to regulatory action may hit DexCom’s product availability, thereby losing in competition, which may lead to a DME share loss. Roche's Accu-Chek SmartGuide, an AI-enabled CGM ...